Transthera Sciences (Nanjing) Inc. has announced the completion of its placing of new H shares under the general mandate. The company confirmed that all conditions of the placing agreement were fulfilled, with completion occurring on January 20, 2026. The announcement emphasized that the placement does not constitute an offer or solicitation to purchase securities in the United States, and the securities have not been registered under the U.S. Securities Act of 1933. The company does not intend to make a public offering of these securities in the United States.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transthera Sciences (Nanjing) Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260120-11995809), on January 20, 2026, and is solely responsible for the information contained therein.